Aloglutamol
Chemical compound
- A02AB06 (WHO)
- Dihydroxyaluminium gluconate; Tris(hydroxymethyl)aminomethane (1:1)
- 13755-41-4
Y
- 28426726
N
- I670EI8M2N
- DTXSID601027584
- Interactive image
- C([C@H]([C@H]([C@@H]([C@H](C(=O)O[Al](O)O)O)O)O)O)O.C(C(CO)(CO)N)O
InChI
- InChI=1S/C6H12O7.C4H11NO3.Al.2H2O/c7-1-2(8)3(9)4(10)5(11)6(12)13;5-4(1-6,2-7)3-8;;;/h2-5,7-11H,1H2,(H,12,13);6-8H,1-3,5H2;;2*1H2/q;;+3;;/p-3/t2-,3-,4+,5-;;;;/m1..../s1
N
- Key:GJJYZOBRHIMORS-GQOAHPRESA-K
N
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Aloglutamol is an antacid, an aluminium compound.[1] It is a salt of aluminium, gluconic acid, and tris.[2][3] It is usually given orally in doses of 0.5 to 1 g.[4] Proprietary names include Altris, Pyreses, Tasto and Sabro.[4][5]
References
- ^ Dikshith TS (1 November 2010). Handbook of Chemicals and Safety. Taylor & Francis US. p. 69. ISBN 978-1-4398-2060-5. Retrieved 29 April 2012.
- ^ Bonanno A, Tonini GM, de Marinis S (1978). "[Use of Aloglutamol in uremic patients on dialysis (author's transl]". Urologia Internationalis (in French). 33 (4): 213–221. doi:10.1159/000280201. PMID 705977.
- ^ Aloglutamol, Comparative Toxicogenomics Database
- ^ a b Martindale W (1993). The Extra Pharmacopoeia. Royal Pharmaceutical Society of Great Britain, Dept. of Pharmaceutical Sciences, Pharmaceutical Press. p. 869. ISBN 978-0-85369-300-0. Retrieved 29 April 2012.
- ^ Negwer M, Scharnow HG (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 157. ISBN 978-3-527-30247-5. Retrieved 29 April 2012.
- v
- t
- e
of aluminium, calcium and magnesium
![]() | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e